These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Iwamoto J; Takeda T; Sato Y Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence. Inderjeeth CA; Foo AC; Lai MM; Glendenning P Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909 [TBL] [Abstract][Full Text] [Related]
5. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns. Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977 [TBL] [Abstract][Full Text] [Related]
6. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Lee WL; Chao HT; Cheng MH; Wang PH Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794 [TBL] [Abstract][Full Text] [Related]
7. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009]. Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K; Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202 [TBL] [Abstract][Full Text] [Related]
8. [Strontium ranelate: a novel concept for the treatment of osteoporosis]. Dimai HP Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353 [TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Liu H; Michaud K; Nayak S; Karpf DB; Owens DK; Garber AM Arch Intern Med; 2006 Jun; 166(11):1209-17. PubMed ID: 16772249 [TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate for osteoporosis? Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933 [TBL] [Abstract][Full Text] [Related]
12. Drug insight: Existing and emerging therapies for osteoporosis. Mulder JE; Kolatkar NS; LeBoff MS Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):670-80. PubMed ID: 17143314 [TBL] [Abstract][Full Text] [Related]
13. Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Epstein S Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639 [TBL] [Abstract][Full Text] [Related]
14. [Osteoporosis treatment]. Uebelhart B; Rizzoli R Rev Med Suisse; 2007 Jan; 3(94):150-3. PubMed ID: 17354541 [TBL] [Abstract][Full Text] [Related]
15. Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid. Prescrire Int; 2005 Feb; 14(75):5-9. PubMed ID: 15747448 [TBL] [Abstract][Full Text] [Related]
16. Bone health and osteoporosis in postmenopausal women. de Villiers TJ Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):73-85. PubMed ID: 19027366 [TBL] [Abstract][Full Text] [Related]
17. The teriparatide in the treatment of severe senile osteoporosis. Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460 [TBL] [Abstract][Full Text] [Related]
18. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada. Hanley DA; Zhang Q; Meilleur MC; Mavros P; Sen SS Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742 [TBL] [Abstract][Full Text] [Related]
19. Recognition of women at risk for fracture and intervention with fast-acting therapies. Derman R Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104 [TBL] [Abstract][Full Text] [Related]